Skip to Main Content

Fractyl Health, Inc. Common Stock

GUTS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
GUTS Income Statement
GUTS Balance Sheet
GUTS Cash Flow

Recent trades of GUTS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
GUTS Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
GUTS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
GUTS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by GUTS's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Methods and systems for treating diabetes and related diseases and disorders Oct. 29, 2024
  • Patent Title: Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract Oct. 01, 2024
  • Patent Title: Ablation systems, devices and methods for the treatment of tissue Sep. 17, 2024
  • Patent Title: Systems, methods and devices for treatment of target tissue May. 21, 2024
  • Patent Title: Systems, devices and methods for performing medical procedures in the intestine Jan. 23, 2024
  • Patent Title: Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract Nov. 28, 2023
  • Patent Title: Systems, devices and methods for performing medical procedures in the intestine Jan. 31, 2023
  • Patent Title: Electrical energy ablation systems, devices and methods for the treatment of tissue Sep. 13, 2022
  • Patent Title: Heat ablation systems, devices and methods for the treatment of tissue Aug. 23, 2022
  • Patent Title: Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract Apr. 26, 2022
  • Patent Title: Methods, systems and devices for performing multiple treatments on a patient Feb. 15, 2022
  • Patent Title: Methods and systems for treating diabetes and related diseases and disorders Nov. 30, 2021
  • Patent Title: Injectate delivery devices, systems and methods Nov. 09, 2021
  • Patent Title: Systems, devices and methods for performing medical procedures in the intestine Aug. 31, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of GUTS in WallStreetBets Daily Discussion

GUTS News

Recent insights relating to GUTS

CNBC Recommendations

Recent picks made for GUTS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GUTS

GUTS Top Shareholders
Shareholder
Shares Held
GUTS Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

GUTS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view GUTS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top